Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy

Gynecologic Oncology

Volumn 132, Issue 1, 2014, Pages 33-37

  Gunderson, Camille C ^a   Dutta, Sonia ^b   Fader, Amanda Nickles ^c   Maniar, Kruti P ^b   Nasseri Nik, Niloo ^b   Bristow, Robert E ^d   Diaz Montes, Teresa P ^b   Palermo, Robert ^c   Kurman, Robert J ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Complex atypical hyperplasia; Estrogen progesterone receptor; Progestin therapy; Well differentiated endometrial adenocarcinoma

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE; MEGESTROL ACETATE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COMPLEX ATYPICAL HYPERPLASIA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; WELL DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA; YOUNG ADULT;

COMPLEX ATYPICAL HYPERPLASIA; ESTROGEN/PROGESTERONE RECEPTOR; PROGESTIN THERAPY; WELL DIFFERENTIATED ENDOMETRIAL ADENOCARCINOMA;

ADULT; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84892797894     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.11.033     Document Type: Article

References (24)

1. D.G. Gallup, and R.J. Stock Adenocarcinoma of the endometrium in women 40 years of age or younger Obstet Gynecol 64 1984 417 420
2. L.A. Brinton, M.L. Berman, R. Mortel, L.B. Twiggs, R.J. Barrett, and G.D. Wilbanks et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study Am J Obstet Gynecol 167 1992 1317 1325
3. V.E. Cullins Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate J Reprod Med 41 1996 428 433
4. F.J. Montz, R.E. Bristow, A. Bovicelli, R. Tomacruz, and R.J. Kurman Intrauterine progesterone treatment of early endometrial cancer Am J Obstet Gynecol 186 2002 651 657
5. W.H. Gotlieb, M.E. Beiner, B. Shalmon, Y. Korach, Y. Segal, and N. Zmira et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
6. T. Jobo, M. Imai, M. Kawaguchi, M. Kenmochi, and H. Kuramoto Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases Eur J Gynaecol Oncol 21 2000 119 122
7. T. Kaku, H. Yoshikawa, H. Tsuda, A. Sakamoto, M. Fukunaga, and Y. Kuwabara et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome Cancer Lett 167 2001 39 48
8. Y.B. Kim, C.H. Holschneider, K. Ghosh, R.K. Nieberg, and F.J. Montz Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature Cancer 79 1997 320 327
9. P.T. Ramirez, M. Frumovitz, D.C. Bodurka, C.C. Sun, and C. Levenback Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review Gynecol Oncol 95 2004 133 138
10. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet Gynecol 90 1997 434 440
11. C.C. Gunderson, A.N. Fader, K.A. Carson, and R.E. Bristow Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review Gynecol Oncol 125 2012 477 482
12. R.J. Kurman, and H.J. Norris Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma Cancer 49 1982 2547 2559
13. W. Remmele, U. Hildebrand, H.A. Hienz, P.J. Klein, M. Vierbuchen, and L.J. Behnken et al. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer Virchows Arch A Pathol Anat Histopathol 409 1986 127 147
14. D.T. Wheeler, R.E. Bristow, and R.J. Kurman Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins Am J Surg Pathol 31 2007 988 998
15. M. Koskas, E. Azria, F. Walker, D. Luton, P. Madelenat, and C. Yazbeck Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility Anticancer Res 32 2012 1037 1043
16. T.J. Cade, M.A. Quinn, R.M. Rome, and D. Neesham Progestogen treatment options for early endometrial cancer BJOG 117 2010 879 884
17. J.L. Hubbs, R.M. Saig, L.N. Abaid, V.L. Bae-Jump, and P.A. Gehrig Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma Obstet Gynecol 121 2013 1172 1180
18. A.B. Vereide, T. Kaino, G. Sager, M. Arnes, and A. Orbo Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia Gynecol Oncol 101 2006 214 223
19. A. Orbo, M. Arnes, I. Pettersen, K. Larsen, K. Hanssen, and B. Moe Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system Acta Obstet Gynecol Scand 89 2010 1438 1446
20. K. Upson, K.H. Allison, S.D. Reed, C.D. Jordan, K.M. Newton, and E.M. Swisher et al. Biomarkers of progestin therapy resistance and endometrial hyperplasia progression Am J Obstet Gynecol 207 2012 36 (e1-8)
21. C.L. Trimble, J. Kauderer, R. Zaino, S. Silverberg, P.C. Lim, and J.J. Burke 2nd et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study Cancer 106 2006 812 819
22. K.R. Penner, O. Dorigo, C. Aoyama, N. Ostrzega, B.L. Balzer, and J. Rao et al. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Gynecol Oncol 124 2012 542 548
23. P.T. Soliman, B.M. Slomovitz, R.R. Broaddus, C.C. Sun, J.C. Oh, and P.J. Eifel et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases Gynecol Oncol 94 2004 456 462
24. R. Zaino, C. Whitney, M.F. Brady, K. DeGeest, R.A. Burger, and R.E. Buller Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study Gynecol Oncol 83 2001 355 362